Revenue grew 51.3%, of which 29.5% were organic, driven by larger volume of treatments; The company’s net profit in 2022 was BRL 114 million; EBITDA reached BRL 673 million, 80% higher than in 2021. SÃO PAULO, March 30, 2023 /PRNewswire/ — Oncoclínicas Group (ONCO3) – the largest group…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.